Your browser doesn't support javascript.
loading
Emergency Department Use in Adolescent and Young Adult Cancer Early Survivors from 2006 to 2020.
Wernli, Karen J; Haupt, Eric C; Chawla, Neetu; Osuji, Thearis; Shen, Ernest; Smitherman, Andrew B; Casperson, Mallory; Kirchhoff, Anne C; Zebrack, Bradley J; Keegan, Theresa H M; Kushi, Lawrence; Baggett, Christopher; Kaddas, Heydon K; Ruddy, Kathryn J; Sauder, Candice A M; Wun, Theodore; Figueroa Gray, Marlaine; Chubak, Jessica; Nichols, Hazel; Hahn, Erin E.
Afiliação
  • Wernli KJ; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Haupt EC; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
  • Chawla N; Kaiser Permanente Southern California, Pasadena, California, USA.
  • Osuji T; Veteran's Affairs Los Angeles County, Los Angeles, California, USA.
  • Shen E; Kaiser Permanente Southern California, Pasadena, California, USA.
  • Smitherman AB; Kaiser Permanente Southern California, Pasadena, California, USA.
  • Casperson M; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Kirchhoff AC; Cactus Cancer Society, Oakland, California, USA.
  • Zebrack BJ; Department of Pediatrics, Huntsman Cancer Institute and the University of Utah, Salt Lake City, Utah, USA.
  • Keegan THM; School of Social Work, University of Michigan, Ann Arbor, Michigan, USA.
  • Kushi L; Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.
  • Baggett C; Division of Research, Kaiser Permanente, Northern California, Oakland, California, USA.
  • Kaddas HK; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Ruddy KJ; Department of Pediatrics, Huntsman Cancer Institute and the University of Utah, Salt Lake City, Utah, USA.
  • Sauder CAM; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Wun T; Division of Surgical Oncology, Department of Surgery, University of California, Davis Medical Center, Sacramento, California, USA.
  • Figueroa Gray M; Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.
  • Chubak J; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Nichols H; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Hahn EE; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Article em En | MEDLINE | ID: mdl-38682323
ABSTRACT

Purpose:

Understanding emergency department (ED) use in adolescent and young adult (AYA) survivors could identify gaps in AYA survivorship.

Methods:

We conducted a cohort study of 7925 AYA survivors (aged 15-39 years at diagnosis) who were 2-5 years from diagnosis in 2006-2020 at Kaiser Permanente Southern California. We calculated ED utilization rates overall and by indication of the encounter (headache, cardiac issues, and suicide attempts). We estimated rate changes by survivorship year and patient factors associated with ED visit using a Poisson model.

Results:

Cohort was 65.4% women, 45.8% Hispanic, with mean age at diagnosis at 31.3 years. Overall, 38% of AYA survivors had ≥1 ED visit (95th percentile 5 ED visits). Unadjusted ED rates declined from 374.2/1000 person-years (PY) in Y2 to 327.2 in Y5 (p change < 0.001). Unadjusted rates declined for headache, cardiac issues, and suicide attempts. Factors associated with increased ED use included age 20-24 at diagnosis [relative risk (RR) = 1.30, 95% CI 1.09-1.56 vs. 35-39 years]; female (RR = 1.27, 95% CI 1.11-1.47 vs. male); non-Hispanic Black race/ethnicity (RR 1.64, 95% CI 1.38-1.95 vs. non-Hispanic white); comorbidity (RR = 1.34, 95% CI 1.16-1.55 for 1 and RR 1.80, 95% CI 1.40-2.30 for 2+ vs. none); and public insurance (RR = 1.99, 95% CI 1.70-2.32 vs. private). Compared with thyroid cancer, cancers associated with increased ED use were breast (RR = 1.45, 95% CI 1.24-1.70), cervical (RR = 2.18, 95% CI 1.76-2.71), colorectal (RR = 2.34, 95% CI 1.94-2.81), and sarcoma (RR = 1.39, 95% CI 1.03-1.88).

Conclusion:

ED utilization declined as time from diagnosis elapsed, but higher utilization was associated with social determinants of health and cancer types.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Adolesc Young Adult Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Adolesc Young Adult Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos